CLINICAL_TRIALS
trial_result
· 2014-04-01
Clinical Trial Update: Clinical Trial Ceftriaxone in Subjects With ALS [Phase 3]
Summary
A Phase 3 clinical trial evaluating ceftriaxone in amyotrophic lateral sclerosis has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01